Advanced search
Publication Cover
Future Cardiology Volume 3, 2007 - Issue 2
Submit an article Journal homepage
80
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Future Strategies for Improving Outcomes in Patients with Diabetes and Acute Coronary Syndromes

David H FitchettUniversity of Toronto St Michaels HospitalTorontoOntarioCanada. Tel: +4168645627 Fax: +4168645159 [email protected]
Pages 115-121 | Published online: 26 Feb 2007

Bibliography

  • Bakhai A , CollinsonJ, FlatherMDet al.: Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK).Int. J. Cardiol., 100, 79–84 (2005).
  • Franklin K , GoldbergRJ, SpencerFet al.: Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events.Arch. Intern. Med., 164, 1457–1463 (2004).
  • Mak KH , MoliternoDJ, GrangerCBet al.: Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries.J. Am. Coll. Cardiol., 30, 171–179 (1997).
  • Gurm HS , LincoffAM, LeeDet al.: Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.J. Am. Coll. Cardiol., 43, 542–548 (2004).
  • Roffi M , ChewDP, MukherjeeDet al.: Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes.Circulation, 104, 2767–2771 (2001).
  • Zuanetti G , LatiniR, MaggioniAPet al.: Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study.J. Am. Coll. Cardiol., 22, 1788–1794 (1993).
  • Crowley A , MenonV, LessardDet al.: Sex differences in survival after acute myocardial infarction in patients with diabetes mellitus (Worcester Heart Attack Study).Am. Heart J., 146, 824–831 (2003).
  • Dotevall A , HasdaiD, WallentinLet al.: Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS.Diabet. Med., 22, 1542–1550 (2005).
  • Hu G , JousilahtiP, QiaoQet al.: Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction.Diabetologia, 48, 856–861 (2005).
  • Malmberg K , RydenL, HamstenAet al.: Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study.Cardiovasc. Res., 34, 248–253 (1997).
  • Stevens RJ , ColemanRL, AdlerAIet al.: Risk factors for myocardial infarction case fatality and stroke case fatality in Type 2 diabetes: UKPDS 66.Diabetes Care, 27, 201–207 (2004).
  • Norhammar A , MalmbergK, DiderholmEet al.: Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.J. Am. Coll. Cardiol., 43, 585–591 (2004).
  • Hasdai D , TopolEJ, KilaruRet al.: Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials.Am. Heart J., 145, 73–79 (2003).
  • Hellermann JP , JacobsenSJ, GershBJet al.: Heart failure after myocardial infarction: a review.Am. J. Med., 113, 324–330 (2002).
  • Timmer JR , OttervangerJP, ThomasKet al.: Long-term, cause-specific mortality after myocardial infarction in diabetes. Eur. Heart J., 25, 926–931 (2004).
  • Lindholm MG , BoesgaardS, Torp-PedersenCet al.: Diabetes mellitus and cardiogenic shock in acute myocardial infarction.Eur. J. Heart Fail., 7, 834–839 (2005).
  • Detre KM , LombarderoMS, BrooksMMet al.: The effect of previous coronary- artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass angioplasty revascularization investigation investigators. N. Engl. J. Med., 342, 989–997 (2000).
  • Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results of all randomized trials of more than 1000 patients. Lancet, 343, 311–322 (1994).
  • Norhammar A , MalmbergK, RydenLet al.: Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction.Eur. Heart J., 24, 838–844 (2003).
  • Yan RT , YanAT, TanMet al.: Underuse of evidence-based treatment partly explains the worse clinical outcomes in diabetic patients with acute coronary syndromes.Am. Heart J., 152, 676–683 (2006).
  • Franklin K , GoldbergRJ, SpencerFet al.: Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events.Arch. Intern. Med., 164, 1457–1463 (2004).
  • Mahaffey KW , GrangerCB, TothCAet al.: Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.J. Am. Coll. Cardiol., 30, 1606–1610 (1997).
  • Keeley EC , BouraJA, GrinesCL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.Lancet, 361, 13–20 (2003).
  • Grines C , PatelA, ZijlstraFet al.: Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials.Am. Heart J., 145, 47–57 (2003).
  • Mehta SR , CannonCP, FoxKAAet al.: Routine vs selective invasive strategies in patients with acute coronary syndromes.JAMA, 293, 2908–2917 (2005).
  • Cannon CP , WeintraubWS, DemopoulosLAet al.: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.N. Engl. J. Med., 344, 1879–1887 (2001).
  • Yusuf S , ZhaoF, MehtaSR, ChrolaviciusS, TognoniG, FoxKK: Clopidogrel in Unstable Angina to Prevent recurrent Events Trial Investigators: effects of clopidogrel in addition to aspirin in patients with acute coronay syndromes without ST segment elevation.N. Engl. J. Med., 345, 494–502 (2001).
  • Roffi M , ChewDP, MukherjeeDet al.: Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST segement elevation acute coronary syndromes.Circulation, 104, 2767–2771 (2001).
  • Brogan GX et al. Jr, Peterson ED, Mulgund J : Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes. Diabetes Care, 29, 9–14 (2006).
  • Gaede P , VedelP, LarsenNet al.: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.N. Engl. J. Med., 348, 383–393 (2003).
  • Younis N , BurnhamP, PatwalaAet al.: Beta-blocker prescribing differences in patients with and without diabetes following a first myocardial infarction.Diabet. Med., 18, 159–161 (2001).
  • Kjekshus J , GilpinE, CaliGet al.: Diabetic patients and beta-blockers after myocardial infarction.Eur. Heart J., 11, 43–50 (1990).
  • Dargie HJ : Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.Lancet, 357, 1385–1390 (2001).
  • Yusuf S , SleightP, PogueJet al.: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.N. Engl. J. Med., 342, 145–153 (2000).
  • Fox KM : The EURopean trial on reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).Lancet, 362, 782–788 (2003).
  • Gerstein HC : Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.Diabetes Metab. Res. Rev., 18(Suppl. 3), S82–S85 (2002).
  • Gustafsson I , TorpP, KoberLet al.: Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study Group.J. Am. Coll. Cardiol., 34, 83–89 (1999).
  • Borghi C , BacchelliS, EspostiDDet al.: Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction.Diabetes Care, 26, 1862–1868 (2003).
  • Nesto RW , ZarichS: Acute myocardial infarction in diabetes mellitus: lessons learned from ACE inhibition.Circulation, 97, 12–15 (1998).
  • Alter DA , KhaykinY, AustinPCet al.: Processes and outcomes of care for diabetic acute myocardial infarction patients in Ontario: do physicians undertreat?Diabetes Care, 26, 1427–1434 (2003).
  • Eagle KA , GoodmanSG, AvezumAet al.: Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE).Lancet, 359, 373–377 (2002).
  • Ohman EM , RoeMT, SmithSCet al. Jr : Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative. Am. Heart J., 148, S34–S39 (2004).
  • Ishihara M , KojimaS, SakamotoTet al.: Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era.Am. Heart. J., 150, 814–820 (2005).
  • Hadjadj S , CoisneD, MaucoGet al.: Prognostic value of admission plasma glucose and HbA in acute myocardial infarction (see comment).Diabet. Med., 21, 305–310 (2004).
  • Ainla T , BaburinA, TeesaluRet al.: The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes.Diabet. Med., 22, 1321–1325 (2005).
  • Ishihara M , InoueI, KawagoeTet al.: Is admission hyperglycemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?Eur. Heart J., 27, 2413–2419 (2006).
  • Kosuge M , KimuraK, KojimaSet al.: Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction.Circ. J., 69, 375–379 (2005).
  • Goyal A , MahaffeyKW, GargJet al.: Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.Eur. Heart J., 27, 1289–1297 (2006).
  • Almbrand B , JohannessonM, SjostrandBet al.: Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study. Eur. Heart J., 21, 733–739 (2000).
  • Davies MJ , LawrenceIG: DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction): theory and practice.Diabetes Obes. Metab., 4, 289–295 (2002).
  • Malmberg K : Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group.Br. Med. J., 314, 1512–1515 (1997).
  • Malmberg K , RydenL, HamstenAet al.: Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes insulin-glucose in acute myocardial infarction.Eur. Heart. J., 17, 1337–1344 (1996).
  • Malmberg KA , EfendicS, RydenLE: Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI.Diabetes Care, 17, 1007–1014 (1994).
  • Malmberg K , RydenL, EfendicSet al.: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.J. Am. Coll. Cardiol., 26, 57–65 (1995).
  • Malmberg K , RydenL, WedelHet al.: Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.Eur. Heart J., 26, 650–661 (2005).
  • van den Berghe G , WoutersP, WeekersFet al.: Intensive insulin therapy in critically ill patients. N. Engl. J. Med., 345, 1359–1367 (2001).
  • Lazar H , ChipkinSR, FitzgeraldCAet al.: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and reduces recurrent ischaemic events.Circulation, 109, 1497–1502 (2004).
  • Mehta SR , YusufS, DiazRet al.: The CREATE-ECLA trial group. Effect of glucose-insulin-potassium infusion on mortality in patients with acute SR segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.JAMA, 293, 437–446 (2005).
  • Pittas AG , SiegelRD, LauJ: Insulin therapy for critically ill hospitalized patients.Ann. Pharmacother., 164, 2005–2011 (2004).
  • Pinto DS , SkolnickAH, KirtaneAJet al.: U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction.J. Am. Coll. Cardiol., 46, 178–183 (2005).
  • Bartnik M , RydenL, FerrariRet al.: The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on Diabetes and the Heart.Eur. Heart J., 25, 1880–1890 (2004).
  • Norhammar A , TenerzA, NilssonGet al.: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.Lancet, 359, 2140–2144 (2002).
  • Bartnik M , MalmbergK, NorhammarAet al.: Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur. Heart J., 25, 1990–1997 (2004).
  • Bartnick M , MalmbergK, NorhammarAet al.: Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur. Heart J., 25, 1990–1997 (2004).
  • UK prospective diabetes study group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet, 352, 837–853 (1998).
  • Cleary PA , OrchardTJ, GenuthSet al.: The effect of intensive glycemic treatment on coronary artery calcification in Type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.Diabetes, 55, 3556–3565 (2005).
  • Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: sustained effect of intensive treatment of Type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA, 290, 2159–2167 (2003).
  • Tuomilehto J : Reducing coronary heart disease associated with Type 2 diabetes: lifestyle intervention and treatment of dyslipidaemia.Diabetes Res. Clin. Pract., 61(Suppl. 1), S27–S34 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.